Cyclerion Therapeutics

KRSA · NASDAQ

$31.03−$0.38 (−1.21%)TodayMarket closed ·
Prev close $31.41

Who owns KRSA

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 85.6% of KRSA’s shares.

  • Kalehua Capital Management LLC35.3%
  • Fidelity Management & Research Company LLC13.9%
  • Hecht (Peter M)9.6%
  • Balyasny Asset Management LP6.8%
  • Next 6 largest institutions20.0%
  • All other shareholders14.4%
Top institutional holders of KRSA
HolderShares% of shares
Kalehua Capital Management LLC1.65M35.29%
Fidelity Management & Research Company LLC649.55K13.88%
Hecht (Peter M)448.22K9.58%
Balyasny Asset Management LP317.51K6.78%
Adar1 Capital Management LLC298.76K6.38%
J. Wood Capital Advisors LLC181.82K3.89%
Braidwell LP156.89K3.35%
American Endowment Foundation133.03K2.84%
Graul (Regina Margaret)107.22K2.29%
Citadel Advisors LLC59.80K1.28%

Largest mutual fund holders

Top mutual fund holders of KRSA
HolderShares% of shares
Fidelity Growth Company Fund31.14K0.67%
Fidelity Growth Company K6 Fund8.67K0.19%
Fidelity Series Growth Company Fund8.19K0.17%
Vanguard Extended Market Index Fund4.42K0.09%
Fidelity Nasdaq Composite Index ETF3.05K0.07%

Short interest

Settled Sep 30, 2026

Shares short
11.55K
Days to cover
1.00
% of shares outstanding
0.25%
Average daily volume
83.65K
Change since last report
+160.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.